296 related articles for article (PubMed ID: 2158104)
21. Identification of a new receptor subtype for tumor necrosis factor-alpha.
Schwalb DM; Han HM; Marino M; Warren R; Porter A; Goh C; Fair WR; Donner DB
J Biol Chem; 1993 May; 268(14):9949-52. PubMed ID: 7683686
[TBL] [Abstract][Full Text] [Related]
22. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
[TBL] [Abstract][Full Text] [Related]
23. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition.
Baglioni C; McCandless S; Tavernier J; Fiers W
J Biol Chem; 1985 Nov; 260(25):13395-7. PubMed ID: 2997166
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma induces cell surface expression for both types of tumor necrosis factor receptors.
Pandita R; Pocsik E; Aggarwal BB
FEBS Lett; 1992 Nov; 312(1):87-90. PubMed ID: 1330686
[TBL] [Abstract][Full Text] [Related]
25. The type B receptor for tumor necrosis factor-alpha mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells.
Greenblatt MS; Elias L
Blood; 1992 Sep; 80(5):1339-46. PubMed ID: 1325213
[TBL] [Abstract][Full Text] [Related]
26. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha).
Hohmann HP; Remy R; Brockhaus M; van Loon AP
J Biol Chem; 1989 Sep; 264(25):14927-34. PubMed ID: 2549042
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.
Engelmann H; Holtmann H; Brakebusch C; Avni YS; Sarov I; Nophar Y; Hadas E; Leitner O; Wallach D
J Biol Chem; 1990 Aug; 265(24):14497-504. PubMed ID: 1696947
[TBL] [Abstract][Full Text] [Related]
28. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses.
Thoma B; Grell M; Pfizenmaier K; Scheurich P
J Exp Med; 1990 Oct; 172(4):1019-23. PubMed ID: 2170559
[TBL] [Abstract][Full Text] [Related]
29. The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity.
Lidbury BA; Rathjen DA; Ramshaw IA; Cowden WB
Biotechnol Ther; 1994; 5(1-2):27-45. PubMed ID: 7703831
[TBL] [Abstract][Full Text] [Related]
30. High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.
Rubin BY; Anderson SL; Sullivan SA; Williamson BD; Carswell EA; Old LJ
J Exp Med; 1985 Sep; 162(3):1099-104. PubMed ID: 2993471
[TBL] [Abstract][Full Text] [Related]
31. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
32. Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells.
Winzen R; Wallach D; Engelmann H; Nophar Y; Brakebusch C; Kemper O; Resch K; Holtmann H
J Immunol; 1992 Jun; 148(11):3454-60. PubMed ID: 1316917
[TBL] [Abstract][Full Text] [Related]
33. Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response.
Pocsik E; Mihalik R; Ali-Osman F; Aggarwal BB
J Cell Biochem; 1994 Apr; 54(4):453-64. PubMed ID: 8014194
[TBL] [Abstract][Full Text] [Related]
34. Cloning, expression and cross-linking analysis of the murine p55 tumor necrosis factor receptor.
Barrett K; Taylor-Fishwick DA; Cope AP; Kissonerghis AM; Gray PW; Feldmann M; Foxwell BM
Eur J Immunol; 1991 Jul; 21(7):1649-56. PubMed ID: 1647956
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
Dunne SL; Bajzer Z; Vuk-Pavlović S
Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
[TBL] [Abstract][Full Text] [Related]
36. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
Tsujimoto M; Yip YK; Vilcek J
J Immunol; 1986 Apr; 136(7):2441-4. PubMed ID: 3005410
[TBL] [Abstract][Full Text] [Related]
37. Selective formation of tumor necrosis factor-alpha (TNF) degradation products contributes to TNF mediated cytotoxicity.
Fruehauf JP; Sinha BK
Oncol Res; 1992; 4(3):91-101. PubMed ID: 1319775
[TBL] [Abstract][Full Text] [Related]
38. Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN.
Israel S; Hahn T; Holtmann H; Wallach D
Immunol Lett; 1986 Apr; 12(4):217-24. PubMed ID: 2424831
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties.
Luo G; Niesel DW; Shaban RA; Grimm EA; Klimpel GR
Infect Immun; 1993 Mar; 61(3):830-5. PubMed ID: 8381771
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines.
Tsujimoto M; Feinman R; Vilcek J
J Immunol; 1986 Oct; 137(7):2272-6. PubMed ID: 3020123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
